N. Sakai

Current surgical treatment for esophageal cancer

Y. Kajiyama, N. Tomita, H. Orita, 2007 .

INDICATION AND LIMITATION OF 3-FIELD LYMPH NODE DISSECTION SURGERY FOR ESOPHAGEAL CANCER FROM SURVIVAL ANALYSIS

Y. Kajiyama, N. Tomita, M. Tsurumaru, 2007 .

Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer.

Y. Kajiyama, N. Tomita, M. Tsurumaru, 2014, Molecular and clinical oncology.

Abstract. To determine the efficacy of postoperative adjuvant chemotherapy with docetaxel + cisplatin + 5-fluorouracil (DCF) in lymph node metastasis-positive esophageal cancer, we retrospectively analyzed 139 patients with stage II/III (non-T4) esophageal cancer with lymph node metastasis (1-6 node

Y. Kajiyama, N. Tomita, M. Tsurumaru, 2014 .

Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions.

Y. Kajiyama, M. Tsurumaru, Y. Iwanuma, 2009, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[Angiographic study of bone tumors--indications for the decision of surgery, with special reference to the hindquarter amputation].

N. Sakai, 1967, Nihon Seikeigeka Gakkai zasshi.

Successfully treated case of cervical abscess and mediastinitis due to esophageal perforation after gastrointestinal endoscopy.

Y. Kajiyama, Y. Iwanuma, M. Tsurumaru, 2002, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma.

K. Mimori, G. Sawada, H. Hirata, 2017, Oncology letters.

EVALUATION OF ULCERATIVE COLITIS AND HLA, PARTICULARLY CLASS II ANTIGEN

M. Kitajima, A. Yagita, I. Tatekawa, 1987 .